IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI

This study aims to determine whether insulin-like growth factor binding protein2 (IGFBP2) is a useful biomarker for early diagnosis of acute kidney injury (AKI), evaluate the therapeutic effects of resveratrol-loaded nanoparticles (Res-NPs), and investigate the possible underlying mechanisms in a ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hai-Lun, Yan, Zhuan, Ke, Zun-Ping, Tian, Xiao-Feng, Zhong, Li-Li, Lin, Yong-Tao, Xu, Yong, Zheng, Dong-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290963/
https://www.ncbi.nlm.nih.gov/pubmed/30564296
http://dx.doi.org/10.18632/oncotarget.25663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290963/
https://www.ncbi.nlm.nih.gov/pubmed/30564296
http://dx.doi.org/10.18632/oncotarget.25663

Ejemplares similares